vs
Side-by-side financial comparison of Cheche Group Inc. (CCG) and ORTHOPEDIATRICS CORP (KIDS). Click either name above to swap in a different company.
ORTHOPEDIATRICS CORP is the larger business by last-quarter revenue ($61.6M vs $32.8M, roughly 1.9× Cheche Group Inc.). Cheche Group Inc. runs the higher net margin — 0.5% vs -16.4%, a 16.9% gap on every dollar of revenue.
Cheche Group Inc. is a leading automotive digital service provider headquartered in China. It offers integrated solutions including auto insurance intermediary services, smart auto after-sales support, and connected vehicle technology products, serving individual car owners, auto dealerships, and insurance partners across domestic and select Southeast Asian markets.
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
CCG vs KIDS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.8M | $61.6M |
| Net Profit | $153.6K | $-10.1M |
| Gross Margin | 5.7% | 73.2% |
| Operating Margin | — | -13.3% |
| Net Margin | 0.5% | -16.4% |
| Revenue YoY | — | 17.0% |
| Net Profit YoY | — | 37.1% |
| EPS (diluted) | $0.00 | $-0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $32.8M | — | ||
| Q4 25 | — | $61.6M | ||
| Q3 25 | — | $61.3M | ||
| Q2 25 | $26.0M | $61.1M | ||
| Q1 25 | — | $52.4M | ||
| Q4 24 | $18.6M | $52.7M | ||
| Q3 24 | — | $54.6M | ||
| Q2 24 | $36.1M | $52.8M |
| Q1 26 | $153.6K | — | ||
| Q4 25 | — | $-10.1M | ||
| Q3 25 | — | $-11.8M | ||
| Q2 25 | $-492.4K | $-7.1M | ||
| Q1 25 | — | $-10.7M | ||
| Q4 24 | $-196.7K | $-16.1M | ||
| Q3 24 | — | $-7.9M | ||
| Q2 24 | $-7.6M | $-6.0M |
| Q1 26 | 5.7% | — | ||
| Q4 25 | — | 73.2% | ||
| Q3 25 | — | 73.9% | ||
| Q2 25 | 4.9% | 72.1% | ||
| Q1 25 | — | 73.0% | ||
| Q4 24 | 5.2% | 67.5% | ||
| Q3 24 | — | 73.4% | ||
| Q2 24 | 4.3% | 77.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | -13.3% | ||
| Q3 25 | — | -15.4% | ||
| Q2 25 | -2.0% | -17.4% | ||
| Q1 25 | — | -21.0% | ||
| Q4 24 | -0.3% | -26.7% | ||
| Q3 24 | — | -10.2% | ||
| Q2 24 | -4.7% | -10.7% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | — | -16.4% | ||
| Q3 25 | — | -19.2% | ||
| Q2 25 | -1.9% | -11.6% | ||
| Q1 25 | — | -20.3% | ||
| Q4 24 | -1.1% | -30.5% | ||
| Q3 24 | — | -14.5% | ||
| Q2 24 | -21.0% | -11.4% |
| Q1 26 | $0.00 | — | ||
| Q4 25 | — | $-0.43 | ||
| Q3 25 | — | $-0.50 | ||
| Q2 25 | $-0.01 | $-0.30 | ||
| Q1 25 | — | $-0.46 | ||
| Q4 24 | $-0.00 | $-0.70 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | — | $-0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $20.0M | $60.9M |
| Total DebtLower is stronger | $193.3K | $106.0M |
| Stockholders' EquityBook value | — | $346.6M |
| Total Assets | $203.5M | $508.6M |
| Debt / EquityLower = less leverage | — | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $20.0M | — | ||
| Q4 25 | — | $60.9M | ||
| Q3 25 | — | $57.7M | ||
| Q2 25 | $23.1M | $70.1M | ||
| Q1 25 | — | $58.8M | ||
| Q4 24 | $21.1M | $68.8M | ||
| Q3 24 | — | $76.1M | ||
| Q2 24 | $28.2M | $28.9M |
| Q1 26 | $193.3K | — | ||
| Q4 25 | — | $106.0M | ||
| Q3 25 | — | $105.3M | ||
| Q2 25 | $690.0K | $102.7M | ||
| Q1 25 | — | $77.4M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $76.9M | ||
| Q2 24 | — | $11.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $346.6M | ||
| Q3 25 | — | $349.3M | ||
| Q2 25 | $47.1M | $355.5M | ||
| Q1 25 | — | $347.1M | ||
| Q4 24 | $49.1M | $354.6M | ||
| Q3 24 | — | $370.9M | ||
| Q2 24 | $48.6M | $371.3M |
| Q1 26 | $203.5M | — | ||
| Q4 25 | — | $508.6M | ||
| Q3 25 | — | $493.5M | ||
| Q2 25 | $177.3M | $503.6M | ||
| Q1 25 | — | $470.3M | ||
| Q4 24 | $177.7M | $473.2M | ||
| Q3 24 | — | $489.3M | ||
| Q2 24 | $139.3M | $430.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.31× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | 0.01× | 0.29× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $10.3M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 15.8% |
| Capex IntensityCapex / Revenue | — | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $10.3M | ||
| Q3 25 | — | $-581.0K | ||
| Q2 25 | $-44.7M | $-10.5M | ||
| Q1 25 | — | $-4.2M | ||
| Q4 24 | $-15.8M | $-4.0M | ||
| Q3 24 | — | $-10.3M | ||
| Q2 24 | $-1.0K | $-6.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $-3.4M | ||
| Q2 25 | — | $-13.9M | ||
| Q1 25 | — | $-8.4M | ||
| Q4 24 | $-16.0M | $-4.2M | ||
| Q3 24 | — | $-11.7M | ||
| Q2 24 | $-1.1K | $-12.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 15.8% | ||
| Q3 25 | — | -5.6% | ||
| Q2 25 | — | -22.8% | ||
| Q1 25 | — | -16.0% | ||
| Q4 24 | -85.9% | -8.1% | ||
| Q3 24 | — | -21.4% | ||
| Q2 24 | -0.0% | -24.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 8.1% | ||
| Q4 24 | 1.2% | 0.5% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | 0.0% | 12.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
